16
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Hyperprolactinemia and prolactinomas.

      Endocrinology and metabolism clinics of North America
      Bromocriptine, therapeutic use, Dopamine Agonists, Ergolines, Humans, Hyperprolactinemia, diagnosis, pathology, therapy, Pituitary Neoplasms, Prolactinoma

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Any process interfering with dopamine synthesis, its transport to the pituitary gland, or its action at the level of lactotroph dopamine receptors can cause hyperprolactinemia. As described in this article, considering the complexity of prolactin regulation, many factors could cause hyperprolactinemia, and hyperprolactinemia can have clinical effects not only on the reproductive axis. Once any drug effects are excluded, prolactinomas are the most common cause of hyperprolactinemia. The most frequent symptom is hypogonadism in both genders. Medical and surgical therapies generally have excellent results, and most prolactinomas are well controlled or even cured in some cases.

          Related collections

          Author and article information

          Journal
          18226731
          10.1016/j.ecl.2007.10.013

          Chemistry
          Bromocriptine,therapeutic use,Dopamine Agonists,Ergolines,Humans,Hyperprolactinemia,diagnosis,pathology,therapy,Pituitary Neoplasms,Prolactinoma

          Comments

          Comment on this article